Evidence map›Paper›PMID 28719755›Full record

ArticleAnnals of the American Thoracic Society2017

Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension.

Mary K Porteous, James C Lee, David J Lederer, Scott M Palmer, Edward Cantu, Rupal J Shah, Scarlett L Bellamy, Vibha N Lama, Sangeeta M Bhorade, Maria M Crespo and 13 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Annals of the American Thoracic Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Extended Use of Central Veno-Arterial Extracorporeal Membrane Oxygenation in Lung Transplantation for Patients with Pulmonary Arterial Hypertension.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Development and validation of primary graft dysfunction predictive algorithm for lung transplant candidates.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2024
    Article
  19. The Impact of Donor Smoking on Primary Graft Dysfunction and Mortality after Lung Transplantation.American journal of respiratory and critical care medicine · 2024
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 13 institutions in 2 countries.

Mary K Porteous1 Department of Medicine.
James C Lee1 Department of Medicine.
David J Lederer2 Department of Medicine, Columbia University Medical Center, New York, New York.
Scott M Palmer3 Department of Medicine, Duke University, Durham, North Carolina.
Edward Cantu4 Department of Surgery, and.
Rupal J Shah5 Department of Medicine, University of California, San Francisco, California.
Scarlett L Bellamy6 Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Vibha N Lama7 Department of Medicine, University of Michigan Health System, Ann Arbor, Michigan.
Sangeeta M Bhorade8 Department of Medicine, Northwestern University, Chicago, Illinois.
Maria M Crespo1 Department of Medicine.
John F McDyer9 Department of Medicine, University of Pittsburgh Medical Center Montefiore Hospital, Pittsburgh, Pennsylvania.
Keith M Wille10 Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
A Russell Localio6 Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Jonathan B Orens11 Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
Pali D Shah11 Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
Ann B Weinacker12 Department of Medicine, Stanford University Medical Center, Stanford, California.
Selim Arcasoy2 Department of Medicine, Columbia University Medical Center, New York, New York.
David S Wilkes13 Department of Medicine, University of Virginia, Charlottesville, Virginia; and.
Lorraine B Ware14 Department of Medicine and.
Jason D Christie1 Department of Medicine.
Steven M Kawut1 Department of Medicine.
Joshua M Diamond1 Department of Medicine.
Lung Transplant Outcomes Group
University of Pennsylvania · USColumbia University Irving Medical Center · USJohns Hopkins University · USDuke University · USNorthwestern University · USPediatrics and Genetics · USStanford Medicine · USUniversity of Alabama at Birmingham · USUniversity of California, San Francisco · USUniversity of Michigan · USUniversity of Virginia · USUPMC Montefiore · USVanderbilt University · US

Funding

Cardiology & pulmonary research training grantT32HL007891 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI Jason D Christie · 1998 to 2026
$12.0M
Clinical Risk Factors for Primary Graft DysfunctionR01HL087115 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CHRISTIE, JASON D · 2007 to 2017
$7.1M
Genetics of primary graft dysfunctionR01HL081619 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CHRISTIE, JASON D · 2007 to 2011
$3.9M
Role of anti-Col (V) immunity in primary graft dysfunctionR01HL096845 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CHRISTIE, JASON D, WILKES, DAVID S · 2010 to 2013
$2.2M
Mentored Patient-Oriented Research in Pulmonary Arterial HypertensionK24HL103844 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI KAWUT, STEVEN M · 2011 to 2020
$1.6M
Lung Transplant donor: prediction, evaluation, and mechanismK23HL116656 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CANTU, EDWARD · 2013 to 2017
$872k
Long Pentraxin-3 genomics and outcomes after lung transplantationK23HL121406 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI DIAMOND, JOSHUA M. · 2014 to 2017
$629k
Advanced diagnostics for donor lung assessment and ex vivo lung perfusion candidate selectionR03HL135227 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CANTU, EDWARD · 2016 to 2017
$161k
NHLBI NIH HHS K23 HL116656NHLBI NIH HHS K23 HL121406NHLBI NIH HHS K24 HL103844NHLBI NIH HHS R01 HL081619NHLBI NIH HHS R01 HL087115NHLBI NIH HHS R01 HL096845NHLBI NIH HHS R03 HL135227NHLBI NIH HHS T32 HL007891
6 · The paper itself

Abstract

rationalePulmonary hypertension from pulmonary arterial hypertension or parenchymal lung disease is associated with an increased risk for primary graft dysfunction after lung transplantation.

objectiveWe evaluated the clinical determinants of severe primary graft dysfunction in pulmonary hypertension and developed and validated a prognostic model.

methodsWe conducted a retrospective cohort study of patients in the multicenter Lung Transplant Outcomes Group with pulmonary hypertension at transplant listing. Severe primary graft dysfunction was defined as Pa

resultsIn the explanatory model of 826 patients with pulmonary hypertension, donor tobacco smoke exposure, higher recipient body mass index, female sex, listing mean pulmonary artery pressure, right atrial pressure and creatinine at transplant, cardiopulmonary bypass use, transfusion volume, and reperfusion fraction of inspired oxygen were associated with primary graft dysfunction. Donor obesity was associated with a lower risk for primary graft dysfunction. Using a 20% threshold for elevated risk, the prognostic model had good negative predictive value in both derivation and validation cohorts (89.1% [95% confidence interval, 85.3-92.8] and 83.3% [95% confidence interval, 78.5-88.2], respectively), but low positive predictive value.

conclusionsSeveral recipient, donor, and operative characteristics were associated with severe primary graft dysfunction in patients with pulmonary hypertension, including several risk factors not identified in the overall transplant population. A prognostic model with donor and recipient clinical risk factors alone had low positive predictive value, but high negative predictive value, to rule out high risk for primary graft dysfunction.

Indexed as

AdultBody Mass IndexFemaleHumansHypertension, PulmonaryLinear ModelsLogistic ModelsLungLung TransplantationMaleMiddle AgedObesityPrimary Graft DysfunctionPrognosisRetrospective StudiesRisk Factorslung transplantationprimary graft dysfunctionpulmonary hypertension

Identifiers

PMID28719755
PMCPMC5718566
OpenAlexW2736506498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.